Terms: = Liver cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Treatment
104 results:
1. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
[TBL] [Abstract] [Full Text] [Related]
2. Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Karapetis CS; Liu H; Sorich MJ; Pederson LD; Van Cutsem E; Maughan T; Douillard JY; O'Callaghan CJ; Jonker D; Bokemeyer C; Sobrero A; Cremolini C; Chibaudel B; Zalcberg J; Adams R; Buyse M; Peeters M; Yoshino T; de Gramont A; Shi Q
Br J Cancer; 2024 May; 130(8):1269-1278. PubMed ID: 38402342
[TBL] [Abstract] [Full Text] [Related]
3. Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal cancer after treatment Termination.
Simmons K; Thomas JV; Ludford K; Willis JA; Higbie VS; Raghav KPS; Johnson B; Dasari A; Kee BK; Parseghian CM; Lee MS; Le PH; Morelli MP; Shen JP; Bent A; Vilar E; Wolff RA; Kopetz S; Overman MJ; Morris VK
Cancer Res Commun; 2023 Dec; 3(12):2510-2517. PubMed ID: 38085001
[TBL] [Abstract] [Full Text] [Related]
4. Comparative Clinicopathologic and Genomic Analysis of Hepatocellular Neoplasm, Not Otherwise Specified, and Hepatoblastoma.
Zhou S; Sarabia SF; Estrine D; Ostrow D; Schmidt RJ; Warren M; Raca G; Shillingford N; Wang L; Pawel B; Stein JE; Biegel JA; Lopez-Terrada D; Mascarenhas L; Ji J
Mod Pathol; 2024 Feb; 37(2):100385. PubMed ID: 37992967
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
6. Neuroblastoma RAS viral oncogene homolog (n-ras) deficiency aggravates liver injury and fibrosis.
Zheng K; Hao F; Medrano-Garcia S; Chen C; Guo F; Morán-Blanco L; Rodríguez-Perales S; Torres-Ruiz R; Peligros MI; Vaquero J; Bañares R; Gómez Del Moral M; Regueiro JR; Martínez-Naves E; Mohamed MR; Gallego-Durán R; Maya D; Ampuero J; Romero-Gómez M; Gilbert-Ramos A; Guixé-Muntet S; Fernández-Iglesias A; Gracia-Sancho J; Coll M; Graupera I; Ginès P; Ciudin A; Rivera-Esteban J; Pericàs JM; Frutos MD; Ramos Molina B; Herranz JM; Ávila MA; Nevzorova YA; Fernández-Malavé E; Cubero FJ
Cell Death Dis; 2023 Aug; 14(8):514. PubMed ID: 37563155
[TBL] [Abstract] [Full Text] [Related]
7. Anatomical resection improves relapse-free survival in colorectal liver metastases in patients with KRAS/nras/BRAF mutations or right-sided colon cancer: a retrospective cohort study.
Chang W; Chen Y; Zhou S; Ren L; Xu Y; Zhu D; Tang W; Ye Q; Wang X; Fan J; Wei Y; Xu J
Int J Surg; 2023 Oct; 109(10):3070-3077. PubMed ID: 37526097
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm].
Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957
[TBL] [Abstract] [Full Text] [Related]
9. Evaluation of
Lastraioli E; Bettiol A; Iorio J; Limatola E; Checcacci D; Parisi E; Bianchi C; Arcangeli A; Iannopollo M; Di Costanzo F; Di Lieto M
Cells; 2023 May; 12(11):. PubMed ID: 37296579
[TBL] [Abstract] [Full Text] [Related]
10. The genomics of liver metastases from colon and rectal cancer: An Invited Commentary (invitation from Lee Ocuin, MD and Kevin Behrns, MD) for the special issue of "Management of Advanced Primary and Secondary liver Malignancies".
Schwantes IR; Mayo SC
Surgery; 2023 Aug; 174(2):422-424. PubMed ID: 37183133
[TBL] [Abstract] [Full Text] [Related]
11. Hepatic passaging of nras-mutant melanoma influences adhesive properties and metastatic pattern.
Dietsch B; Weller C; Sticht C; de la Torre C; Kramer M; Goerdt S; Géraud C; Wohlfeil SA
BMC Cancer; 2023 May; 23(1):436. PubMed ID: 37179302
[TBL] [Abstract] [Full Text] [Related]
12. The efficacy and adverse effects of nivolumab and lenvatinib in the treatment of advanced hepatocellular carcinoma.
Wen S; Zeng J; Zhong L; Ye J; Lai X
Cell Mol Biol (Noisy-le-grand); 2022 Nov; 68(11):53-57. PubMed ID: 37114307
[TBL] [Abstract] [Full Text] [Related]
13. Spontaneous rupture of a solitary oligometastatic hepatic melanoma.
Tiong J; Rajagopalan A; Jaya J; Sritharan M
BMJ Case Rep; 2023 Feb; 16(2):. PubMed ID: 36731945
[TBL] [Abstract] [Full Text] [Related]
14. Correlation Analysis of Gene and Radiomic Features in Colorectal cancer liver Metastases.
Wang X; Li N; Guo H; Yin X; Zheng Y
Comput Math Methods Med; 2022; 2022():8559011. PubMed ID: 36593900
[TBL] [Abstract] [Full Text] [Related]
15. Cobimetinib Plus Vemurafenib in Patients With Colorectal cancer With
Klute KA; Rothe M; Garrett-Mayer E; Mangat PK; Nazemzadeh R; Yost KJ; Duvivier HL; Ahn ER; Cannon TL; Alese OB; Krauss JC; Thota R; Calfa CJ; Denlinger CS; O'Lone R; Halabi S; Grantham GN; Schilsky RL
JCO Precis Oncol; 2022 Nov; 6():e2200191. PubMed ID: 36409971
[TBL] [Abstract] [Full Text] [Related]
16. Personalized targeted therapy prescription in colorectal cancer using algorithmic analysis of RNA sequencing data.
Sorokin M; Zolotovskaia M; Nikitin D; Suntsova M; Poddubskaya E; Glusker A; Garazha A; Moisseev A; Li X; Sekacheva M; Naskhletashvili D; Seryakov A; Wang Y; Buzdin A
BMC Cancer; 2022 Oct; 22(1):1113. PubMed ID: 36316649
[TBL] [Abstract] [Full Text] [Related]
17. The role of TBK1 in cancer pathogenesis and anticancer immunity.
Runde AP; Mack R; S J PB; Zhang J
J Exp Clin Cancer Res; 2022 Apr; 41(1):135. PubMed ID: 35395857
[TBL] [Abstract] [Full Text] [Related]
18. Circulating Cell-Free DNA Captures the Intratumor Heterogeneity in Multinodular Hepatocellular Carcinoma.
Coto-Llerena M; Benjak A; Gallon J; Meier MA; Boldanova T; Terracciano LM; Ng CKY; Piscuoglio S
JCO Precis Oncol; 2022 Mar; 6():e2100335. PubMed ID: 35263170
[TBL] [Abstract] [Full Text] [Related]
19. Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).
Liu L; Erickson NT; Ricard I; von Weikersthal LF; Lerch MM; Decker T; Kiani A; Kaiser F; Heintges T; Kahl C; Kullmann F; Scheithauer W; Link H; Höffkes HG; Moehler M; Gesenhues AB; Theurich S; Michl M; Modest DP; Algül H; Stintzing S; Heinemann V; Holch JW
Int J Cancer; 2022 Jan; 150(1):112-123. PubMed ID: 34431518
[TBL] [Abstract] [Full Text] [Related]
20. Cross-platform comparison of next-generation sequencing and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for detecting KRAS/nras/BRAF/PIK3CA mutations in cfDNA from metastatic colorectal cancer patients.
Xu X; Huang F; Cao M; Chen X; Wang H; Jiang H; Yu Y; Shen M; Yang Y; Wang B; Liu T; Guo W
J Clin Lab Anal; 2021 Sep; 35(9):e23818. PubMed ID: 34403504
[TBL] [Abstract] [Full Text] [Related]
[Next]